AnimalBiome (Series A(+))
Funding Details
Awarder
SOSV
Date Award
May 13, 2024
Vertical
Microbiome-based diagnostics and supplements
Company Info
Founders
Holly H. Ganz, PhD
Market
Pets with chronic digestive disorders
Location
United States
Company Description

AnimalBiome creates microbiome-based therapeutics to treat the more than nine million cats and dogs in the U.S. living with chronic digestive disorders. We have developed a process for creating a fecal microbiota transplant pill that is stable at room temperature and highly effective.